| abstract |
The present invention relates to a novel drug for oral or topical administration in the treatment of protozoal infections. Embedded image [Wherein R 1 is a saturated or unsaturated hydrocarbon group having 12 to 20 C atoms, and independently of each other, hydrogen, a C 1 -C 5 -alkyl group, a C 3 -C 6 -cycloalkyl group or A C 1 -C 5 -hydroxyalkyl group, in which case two of R 2 , R 3 and R 4 groups may form a C 2 -C 5 -alkylene group which may be mutually substituted. Wherein R 5 is hydrogen, a C 1 -C 5 -alkyl group, a C 3 -C 6 -cycloalkyl group or a C 1 -C 5 -hydroxyalkyl group. Contains conventional auxiliaries for preparations. [Selection diagram] None |